Login / Signup

Importance of immunoglobulin therapy for COVID-19 patients with lymphocytopenia.

Heba K Nabih
Published in: Bulletin of the National Research Centre (2021)
Through the current review, it was concluded that this passive immunization may promote the immunity to better fight against the virus, so the survival of the patients could be kept longer. The efficacy of immunotherapy with IVIg would be greater if the immune IgG antibodies were collected from convalescent plasma therapy.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • sars cov
  • prognostic factors
  • free survival
  • mesenchymal stem cells